Manipulating the fatty acid composition including CLA content of animal products
-
Upload
phillip-todd -
Category
Documents
-
view
34 -
download
3
description
Transcript of Manipulating the fatty acid composition including CLA content of animal products
Manipulating the fatty acid composition including CLA content
of animal products
Professor, Dr. Peter Buttery
Division of Biochemistry & Nutrition
Biosciences School
The University of Nottingham UK
Why Manipulate the fatty acid composition of animal products?
• To reduce the intake of “bad” fatty acids by the consumer
• To increase the intake of “good” fatty acids by the consumer
• To increase sales of such products by improving their “image”
Dietary Reference Values for Fatty AcidsPopulation averages (% total energy)
1991
Saturated Fatty Acids 10%Cis polyunsaturated fatty acids 6%Cis monounsaturated fatty acids 12%Trans fatty acids 2%Total Fatty Acids 30%
Further Recommendations1994
Population average consumption of long chain n-3 polyunsaturated fatty acids should double (from 0.1g/day to 0.2g/day
(not going to discus this here but is important)
Saturated fatty acid (SFA) intake in Great Britain
0
2
4
6
8
10
12
14
16
18
1992 1993 1994 1995 1996 1997 1998 1999 2000
perc
ent
ener
gy f
rom
SF
A
target
Source: National Food Survey 2000
Contribution of Animal Products to Saturated Fatty Acid (SFA) Intake in Great Britain
National Food Survey 2000
Dairy39%
Meat22%
Other39%
012
345
6
SF
A p
er day (g)
milk
& cream
cheese
bu
tter
eggs
beef
lamb
pork
pou
ltry
other m
eat
• Meat contributes about 22% of total and saturated fat intake in the human diet
• Lamb has a high stearate content which gives a waxy texture, producing poor organoleptic properties
• Red meat, as part of a balanced diet, is an important source of protein and iron
• Meat contributes about 22% of total and saturated fat intake in the human diet
• Lamb has a high stearate content which gives a waxy texture, producing poor organoleptic properties
• Red meat, as part of a balanced diet, is an important source of protein and iron
• Change fatty acid profile of diet ~ low fat diet ~ biohydrogenation of unsaturated fat
• Protected fatty acids
• Manipulation of de novo fat synthesis that is reduce the fat content of the carcass
• Change fatty acid profile of diet ~ low fat diet ~ biohydrogenation of unsaturated fat
• Protected fatty acids
• Manipulation of de novo fat synthesis that is reduce the fat content of the carcass
Possible Approaches
Possible Approaches
Reduction of fat
• Breeding• Diet• Growth Hormone *• Beta agonists*• CLA?
• *Not legal in Europe but are in many parts of the world----China?
Fatty acid composition of intramuscular fat in pigs fed different oils
0
510
1520
2530
3540
45
50
Fatty acid (g/100g total)
C14:0 C16:0 C18:0 C18:1 C18:2 C18:3
LFHF (SO)HF (RO)
Entire male Landrace*Large White Pigs (3 per group) were grown from 55kg to 120kgLF diet: no added fatSO diet: 43.5g/kg sunflower oil + 31.5g/kg rape seed oilRO diet: 75g/kg rape seed oilBudd, Salter, Buttery & Wiseman, unpublished data
THE RUMINANT
• Fats over 10% cause problems with rumen function
• Unsaturated fats are hydrogenated in the rumen so difficult to alter the diet.
Adipose Tissue Fatty Acid Deposition in Ruminant Adipose Tissue
DIET
C18:1/C18:2/C18:3
C18:0
DE NOVO SYNTHESIS
C16:0
C18:0
C18:1
Adipose Tissue
Rumen
Fatty acid composition abomasal fluid and adipose tissue of sheep fed on grass nuts
0
10
20
30
40
50
60
70
fatty acid (g/100g F
AM
E)
14:0 16:0 16:1 18:0 c18:1 t18:1 18:2 18:3
dietabomasumsubcutaneous
Sources of Ruminant Milk Saturated Fatty Acids
Acetate/-OH Butyrate
C4:0-C14:0C16:0
C18:0
Adipose TissueDiet
Mammary Gland
C18:1
Comparison of the fatty acid composition of duodenal fluid and milk from cows
0
10
20
30
40
50
60
Fatty acid (g/100g total)
<12
12:0
14:0
14:1
16:0
16:1
18:0
t18:1
c18:1
18:2
18:3
duodenum
milk
Fatty acid synthesis in adipose tissue & mammary gland
Acetyl CoA
C16:0
C18:0
C18:1
Acetyl CoA
C16:0
C18:0
C18:1
Malonyl CA Malonyl CA
Acetyl CoA Carboxylase(ACC)
Fatty Acid Synthase(FAS)
Elongase
Stearoyl CoA Desaturase(SCD)
MAMMARY ADIPOSE
Correlation between SCD mRNA and oleate content of omental adipose tissue of growing sheep
y = 0.3542x - 7.1498
R2 = 0.9505
0
100
200
300
400
500
600
0 200 400 600 800 1000 1200 1400 1600 1800
SCD mRNA (arbitrary units)
Effect of insulin on SCD gene expression & oleate synthesis in ovine adipose tissue explants
0
1000
2000
3000
4000
acet
ate
inco
rp (
nMol
es)
MUFA
SFA
0
0.5
1
1.5
2
2.5
3
SCD
mR
NA
(ar
b un
its)
cont ins dex ins + dex
cont ins dex ins + dex
Ins: 20nM InsulinDex: 10nM Dexamethosone
Effect of feeding forage or concentrate-based diets on acetyl CoA carboxylase(ACC) & stearoyl CoA desaturase(SCD) mRNA
concentrations of subcutaneous adipose tissue in sheep
0
10
20
30
40
50
60
70
80
mR
NA
(ar
b. U
nit
s/g
tiss
ue)
ACC SCD
forageconc (150)conc (350)
P<0.001
Effect of feeding forage or concentrate-based diets on fatty acid composition of subucateous
adipose tissue in sheep
0
5
10
15
20
25
30
35
fatty acid (g/100g)
14:0 16:0 16:1 18:0 c18:1 t18:1 18:2 18:3
grass
conc (150)
conc (350)
PROTECT FAT FROM RUMEN
• Coat the fat so that it escapes the action of the rumen bacteria
• The coat is then broken down in either abomasum or the duodenum
Effect of feeding rumen- protected fish oil on the muscle fatty acid content of lot-fed cattle
Ashes et al (2000) Recent Advances in Animal Nutrition, 129-140
0
5
10
15
20
25
30
35
40
fatt
y ac
id (
g/10
0g)
14:0 16:0 18:0 c18:1 t18:1 18:2(n-6)
18:3(n-3)
20:5(n-3)
22:6(n-3)
control
Max-EPA
Trans-10, cis 12-CLA
Cis- 9, trans 11-CLA
Linoleic acid
Why interested in CLAs?Suggested health benefits to humans
• Altered nutrient partitioning and lipid metabolism
• Antiatherogenic• Anticarcinogenic• Antidiabetic (type II diabetes)• Immunity enhancement• Improved bone mineralization
Production of CLAs in the rumen Linoleic Acid
cis-9, cis-12 18:2
cis-9, trans-11 CLA
trans-11 18:1
Stearic acid
trans-10, cis-12 CLA
trans-10 18:1
Production of CLA
t11 C18:1
Linoleic acid
c9, t11
Stearic acid
Rumen
t11 C18:1
Adipose tissue
c9, t11
Stearic acid
SCD
Linoleic acid
Effect of feeding forage or concentrate-based diets on the CLA content of abomassal fluid, subcutaneous adipose tissue
& L. dorsi muscle of sheep
0
0.2
0.4
0.6
0.8
1
1.2
1.4
FA
ME
(g/
100g
)
forage conc (150) conc (350)
abomassal
subcut
muscle
0
0.2
0.4
0.6
0.8
1
1.2
1.4
FA
ME
(g/
100g
)
forage conc (150) conc (350)
abomassal
subcut
muscle
cis 9, trans 11 trans 10, cis 12
Seasonal variation in cis 9, trans 11-CLA content of milk
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
fam
e (g
/100
g)
feb mar april may june july aug sept oct nov dec
SCD ACTIVITY
• There is some evidence that there is genetic variation
• Some cows seems to produce more CLA in the diet than others.Polymorphisms in the SCD gene?
• We have not been able to find much variation in adipose tissue and liver of sheep
Production of CLA-enriched butterIp et al (1999) J Nutr 129: 2135-2142
0
5
10
15
20
25
30
g/10
0g t
otal
FA
<12:0 12:0 14:0 16:0 18:0 c18:1 t18:1 18:2 CLA
control
enriched
Cows fed 5.3% sunflower oil and selected for CLA production
Effect of CLA on development of Mammary Cancer in rats
TreatmentGroup
Dietary CLAg/100g
Tumourincidence (%)*
Control 0.1 93
CLA-enrichedButter+
0.8 43
*30 rats per group were treated with a chemical carcinogen. Values represent the number of animals with tumoursadapted from Ip et al (1999) J. Nutr 129:2135-2142+ primarily cis-9, trans-10 isomer
Could it be used in humans?
• Rats were fed 20% (w/w) butter• Rats weighed 180g and would probably consume about
10g of food a day (2g) butter• This is equivalent to 11g butter/kg body weight/day• Thus a 70kg man would have to consume 770g
butter/day to get the same amount• More research is needed• Professor Bauman in the USA working in the area
Manipulating supply of CLA to sheep tissues
• Rumen saturates fatty acids therefore need to protect CLA supplement (containing equal levels c-9,t-11 and t-10,c-12) from ruminal degradation to absorption in small intestine
Not protected Protected
CLA C18:0 CLA CLA
Rumen protected CLA
0
10
20
30
40
50
60
70
% r
each
ing
du
oden
um
CLA-80 pCLA-80
c9,t11t10,c12
CLA-80 protected by Trouw Nutrition: Used matrix of saturated fat of vegetable origin and final product produced by prilling, spray drying and spray chilling.
Determined to be ~ 70 % protected in cannulated sheep by dual-phase markers
Proportion of ingested CLA reaching Duodenum
How much do we feed?
• Ostrowska et al., (1999) • Growing pigs fed CLA-55 (mixture of both isomers)
0, 1.25, 2.5, 5, 7.5, 10g CLA/kg diet
• Fat deposition decreased with increasing CLA• Fat:lean decreased with increasing CLA
• Av 80 kg pig @ highest dose = 0.19 g CLA/kg body weight/day
How much do we feed?
• PCLA ~ 66 % effective at bypassing rumen biohydrogenation
• High levels lipid adversely affect rumen function
• Max amount PCLA supplied daily to small intestine of av. 40 kg lamb calculated = 0.28 kg CLA/kg BW
• Predicted that lambs would consume 1 kg DM/day therefore highest PCLA inclusion was 100 g/kg DM
• 25 and 50g/kg DM groups for dose response
Trial Outline
• 36 ewe lambs Inclusion g/kg feed GE/day (MJ)
1. Control (n=6) 18.42
2. Low PCLA (n=5) 25 19.42
3. Med PCLA (n=5) 50 19.86
4. Hi PCLA (n=5) 100 21.30
5. Low Megalac (n=5) 21.7 19.14
6. Med Megalac (n=5) 43.3 19.86
7. Hi Megalac (n=5) 86.6 21.30
• Megalac controls for lipid coating of PCLA
• Fed for 10 wks, control group designed to grow at 180 g/d
Sample analysis
• Fatty acid composition
– Did the CLA get into the animals tissues?
• Carcass characteristics
– Repartitioning effects of CLA?
Subcutaneous CLA content
0
0.5
1
1.5
2
2.5
mol
es/1
00 m
oles
Control 25 50 100
Amount of supplementpCLAMeg
0
0.5
1
1.5
2
2.5
mol
es/1
00 m
oles
Control 25 50 100
Amount of supplementpCLAMeg
cis-9, trans-11 trans-10, cis-12
Omental CLA content
0
0.5
1
1.5
2
2.5
mol
es/1
00 m
oles
Control 25 50 100
Amount of supplementpCLAMeg
0
0.5
1
1.5
2
2.5
mol
es/1
00 m
oles
Control 25 50 100
Amount of supplementpCLAMeg
cis-9, trans-11 trans-10, cis-12
Perirenal CLA content
0
0.5
1
1.5
2
2.5
mol
es/1
00 m
oles
Control 25 50 100
Amount of supplementpCLAMeg
0
0.5
1
1.5
2
2.5
mol
es/1
00 m
oles
Control 25 50 100
Amount of supplementpCLAMeg
cis-9, trans-11 trans-10, cis-12
L. dorsi CLA content
0
0.5
1
1.5
2
2.5
mol
es/1
00 m
oles
Control 25 50 100
Amount of supplementpCLAMeg
0
0.5
1
1.5
2
2.5
mol
es/1
00 m
oles
Control 25 50 100
Amount of supplementpCLAMeg
cis-9, trans-11 trans-10, cis-12
Liver CLA content
0
0.5
1
1.5
2
2.5
mol
es/1
00 m
oles
Control 25 50 100
Amount of supplementpCLAMeg
0
0.5
1
1.5
2
2.5
mol
es/1
00 m
oles
Control 25 50 100
Amount of supplementpCLAMeg
cis-9, trans-11 trans-10, cis-12
Effect of dietary CLA on carcass fat
100
150
200
250
300
Fat
(g/
kg)
Control 25 50 100
Amount supplement
pCLAMeg
Carcass characteristics
• No change in carcass composition Carcass cold weight Back fat thickness Omental and perirenal depot whole weights Muscle weight (L. Dorsi, V. Lateralis, S.
Tendenosus) Eye muscle depth or width Liver weight
BUT definite incorporation of CLA into tissues
Accumulation of CLA(t10,c12) in subcutaneous adipose tissue
0
0.2
0.4
0.6
0.8
CL
A(t
10,c
12)g
/100
g F
A
0 0.2 0.4 0.8 1.2 1.4 1.6 2.8 5.6
Dietary CLA(t10,c12) (g/kg diet)
pigsheep
Pig data: adapted from Ostrowska et al (2003)
Effect of dietary CLA on carcass fat
100
150
200
250
300
350
Fat
(g/
kg)
0 0.2 0.4 0.8 1.2 1.6
dietary CLA(t10,c12) (g/kg)
100
150
200
250
300
Fat
(g/
kg)
0 1.4 2.8 5.6
dietary CLA(t10,c12) (g/kg)*
pCLAMeg
PIGS SHEEP
Adapted from Ostrowska et al (2003)
*Corrected for protection
Conclusion
• Tissue CLA content increased but no effect on carcass
• Maybe ruminant adipose tissue responds differently to monogastrics?
Conclusions
• Animal products continue to supply a major proportion of dietary saturated fatty acids
• SCD plays a major role in determining the nature of fatty acids synthesized in tissues
• It is possible to increase the concentration of “healthy” fatty acids (e.g. n-3 PUFA & CLA) in meat & dairy produce but whether the changes can be great enough to have a significant impact on human health remains to be established
Acknowledgement
• Professor Andrew Salter
• Dr Sean Richards
• Dr Zoe Daniel
• Dr Richard Wynn